Advanced in Pernicious Anemia

Dr. Michael Maroules

Hematology Oncology | Hematology | Oncology
Smgh Physician Practice Management LLC
350 Boulevard, 
Passaic, NJ 
Advanced in Pernicious Anemia
Smgh Physician Practice Management LLC
350 Boulevard, 
Passaic, NJ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Maroules is a Hematologist Oncology specialist and a Hematologist in Passaic, New Jersey. Dr. Maroules is rated as an Advanced provider by MediFind in the treatment of Pernicious Anemia. His top areas of expertise are Thrombocytopenia, Myelodysplastic Syndrome (MDS), Pulmonary Embolism, Splenectomy, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 87 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Pernicious Anemia.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in NJ
Hospital Affiliations
St Mary's General Hospital
Saint Clare's Hospital/ Denville Campus
St Joseph's University Medical Center Inc
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

SMGH PHYSICIAN PRACTICE MANAGEMENT LLC
350 Boulevard, Passaic, NJ 07055
Other Locations
ST MARYS GENERAL MEDICAL GROUP PC
1100 Clifton Ave, Suite 1b, Clifton, NJ 07013

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer With Recurrence Score (RS) of 25 or Less. RxPONDER: A Clinical Trial Rx for Positive Node, Endocrine Responsive Breast Cancer
A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer With Recurrence Score (RS) of 25 or Less. RxPONDER: A Clinical Trial Rx for Positive Node, Endocrine Responsive Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Drug, Other
Study Drugs: Anastrozole, Exemestane, Letrozole, Systemic Chemotherapy
Study Phase: Phase 3
Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women With Breast Cancer
Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women With Breast Cancer
Enrollment Status: Completed
Publish Date: September 05, 2025
Intervention Type: Procedure
Study Phase: Phase 3
A Randomized, Open Label, Phase III Trial to Evaluate the Efficacy and Safety of Palbociclib + Anti-HER2 Therapy + Endocrine Therapy vs. Anti-HER2 Therapy + Endocrine Therapy After Induction Treatment for Hormone Receptor Positive (HR+)/HER2-Positive Metastatic Breast Cancer
A Randomized, Open Label, Phase III Trial to Evaluate the Efficacy and Safety of Palbociclib + Anti-HER2 Therapy + Endocrine Therapy vs. Anti-HER2 Therapy + Endocrine Therapy After Induction Treatment for Hormone Receptor Positive (HR+)/HER2-Positive Metastatic Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 11, 2025
Intervention Type: Drug
Study Drugs: Palbociclib, Trastuzumab, Pertuzumab, Letrozole, Anastrozole, Exemestane, Fulvestrant
Study Phase: Phase 3
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: January 13, 2025
Intervention Type: Radiation, Procedure
Study Phase: Phase 3
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
Enrollment Status: Terminated
Publish Date: April 05, 2023
Intervention Type: Other, Drug
Study Drug: Aspirin
Study Phase: Phase 3
View 4 Less Clinical Trials

87 Total Publications

Metastatic Clear Cell Carcinoma of Unknown Primary Origin in an Elderly Female Patient With Paraneoplastic Hypercalcemia.
Metastatic Clear Cell Carcinoma of Unknown Primary Origin in an Elderly Female Patient With Paraneoplastic Hypercalcemia.
Journal: Cureus
Published: January 17, 2024
Similar Doctors
Distinguished in Pernicious Anemia
Dr. Veronica C. Zaharia
Hematology | Oncology
Distinguished in Pernicious Anemia
Dr. Veronica C. Zaharia
Hematology | Oncology
32 Union Square, Ste 511, 
New York, NY 
 (11.7 miles away)
212-995-0422
Languages Spoken:
English, German, Hungarian, Romanian, Spanish
See accepted insurances
Offers Telehealth

Veronica Zaharia is a Hematologist and an Oncologist in New York, New York. Dr. Zaharia is rated as a Distinguished provider by MediFind in the treatment of Pernicious Anemia. Her top areas of expertise are Glossitis, Pernicious Anemia, Vitamin B12 Deficiency, and Subacute Combined Degeneration.

Distinguished in Pernicious Anemia
Dr. Mikhail G. Grinberg
Hematology Oncology | Hematology | Oncology
Distinguished in Pernicious Anemia
Dr. Mikhail G. Grinberg
Hematology Oncology | Hematology | Oncology

Hematology Oncology Associates Of Brooklyn, Llp

1660 E 14th St, Suite 401, 
Brooklyn, NY 
 (19.6 miles away)
718-382-8500
Languages Spoken:
English
See accepted insurances

Mikhail Grinberg is a Hematologist Oncology specialist and a Hematologist in Brooklyn, New York. Dr. Grinberg is rated as a Distinguished provider by MediFind in the treatment of Pernicious Anemia. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Glossitis, and Pernicious Anemia.

Distinguished in Pernicious Anemia
Dr. Joseph Lebowicz
Hematology Oncology | Hematology | Oncology
Distinguished in Pernicious Anemia
Dr. Joseph Lebowicz
Hematology Oncology | Hematology | Oncology

Hematology Oncology Associates Of Brooklyn, Llp

1660 E 14th St, Suite 401, 
Brooklyn, NY 
 (19.6 miles away)
718-382-8500
Languages Spoken:
English
See accepted insurances

Joseph Lebowicz is a Hematologist Oncology specialist and a Hematologist in Brooklyn, New York. Dr. Lebowicz is rated as a Distinguished provider by MediFind in the treatment of Pernicious Anemia. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Glossitis, and Pernicious Anemia.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Maroules's expertise for a condition
ConditionClose
    View All 40 Advanced Conditions
    View All 148 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile